Verrica Pharmaceuticals Statistics
NASDAQ: VRCAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.14-0.07 (-1.66%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Verrica Pharmaceuticals by the numbers
Verrica Pharmaceuticals has a market capitalization of $71.1 million based on 17.18M shares outstanding. With trailing EPS of $-1.75, Verrica Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.0% below its 50-day average and 31.1% below its 200-day average.
Average daily trading volume is 62.77K shares, or about $259,847 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VRCA valuation vs. peer median
| Metric | VRCA | Peer median | Difference |
|---|---|---|---|
| Market cap | $71.12M | $72.70M | -2% |
| Avg. volume | 62.77K | 514.02K | -88% |
Peer median across 8 companies: OSTX, MAIA, GANX, HRTX, TENX, CING, HYFT, LFVN.
Valuation
- Market cap
- $71.12M
- EPS (TTM)
- $-1.75
- Shares outstanding
- 17.18M
Price and trading
- Previous close
- 4.21
- Open
- 4.27
- Day range
- 4.06 – 4.33
- 52-week range
- 3.28 – 9.82
- 52-week change
- -10.20%
- Beta
- —
- Volume
- 47.55K
- Average volume
- 62.77K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 71.12M
- Forward Pe
- -2.80
- Eps
- -1.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.82
- Week52 Low
- 3.28
- Avg Volume
- 62,765.00
- Shares Outstanding
- 17.18M
- Ma50
- 4.93
- Ma200
- 6.01
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -57.85%
- Pct From52w Low
- 26.22%